Skip to content
healthcare.dev

oxybutynin chloride

NDC 16729-317, oxybutynin chloride, tablet, extended release, from Accord Healthcare, Inc..

Product NDC
16729-317
Status
Listed
Labeler
Accord Healthcare, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207138
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16729-317 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXYBUTYNIN CHLORIDE5 mg/1

Pharmacologic classes

Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]

Package NDCNDC-11Package
16729-317-0116729031701100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-317-01)
16729-317-1616729031716500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-317-16)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/61496a1e-17bf-4f45-a20c-5bb98fe545ee
  • NADAC price for package 16729031716

    GET /v1/drugs/nadac/16729031716

Use it

Look up 16729-317 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16729-317 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16729-317. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.